GlassScriptPhysician profile
Rachel Wallace Doby
NPI 1790386829
$1,663.14
in general payments reported to CMS, 2019-2025
19 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $275 · 2022: $382 · 2023: $563 · 2024: $275 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $460.83 | 2021-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $407.22 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.55 | 2021-2023 | Stiolto Respimat, Spiriva Respimat |
| Amgen INC. | $97.65 | 2021-2023 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $91.99 | 2022-2024 | Farxiga |
| Exact Sciences Corporation | $82.50 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $61.28 | 2023 | Xarelto |
| Corcept Therapeutics | $57.69 | 2025 | Korlym |
| Amarin Pharma, INC. | $44.13 | 2021-2022 | |
| Abbvie INC. | $43.67 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $29.65 | 2022-2023 | Rexulti |
| Glaxosmithkline, LLC. | $27.92 | 2022-2023 | Trelegy Ellipta |
| Gilead Sciences, INC. | $27.21 | 2025 | |
| Medtronic, INC. | $24.03 | 2024 | Intellis Adaptivestim |
| Grifols USA, LLC | $19.82 | 2024 | Prolastin-C Liquid |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $19.08 | 2024 | Uptravi, Opsumit |
| Lundbeck LLC | $18.89 | 2023 | Rexulti |
| Organogenesis INC. | $17.26 | 2024 | |
| Hologic Sales and Service, LLC | $13.77 | 2025 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Doby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.